🇺🇸 FDA
Patent

US 9441048

Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9441048 (Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Health and Human Services
Grant date
Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/39558, A61K47/68